Abbott announced today that the company has received the Health Canada license of its free FreeStyle LibreLink mobile app for use with compatible iOS smartphones. Canada is the first North American country to have access to this real-time diabetes management digital health tool.
The FreeStyle LibreLink app is designed for use with the FreeStyle Libre sensor, which measures glucose levels with a toonie-sized sensor worn on the upper arm.
The app also enables users to scan their FreeStyle Libre sensor using their iPhone to instantly capture and view their real-time glucose level, their eight-hour glucose history, and a directional arrow indicating how their glucose is changing. Similar to the reader, FreeStyle LibreLink also includes a series of in-app reports that visualize trends and patterns that help patients understand how well they are controlling their glucose.
- With the app, conveniently check glucose by scanning the sensor using the iPhone
- View current glucose reading, a trend arrow (which indicates how glucose is changing), and the last 8 hours of glucose history
- Add notes to track food intake, insulin use, exercise, and other events
- Have the option to automatically share glucose information with healthcare professional or caregivers
- Use without WiFi. The app does not require a WiFi or mobile data connection to scan sensor or to record your current glucose readings.
The FreeStyle LibreLink app is compatible with Near-field Communication (NFC) enabled iPhone 7 and higher running iOS 11 or higher.
For more than 125 years, Abbott has brought new products and technologies to the world in nutrition, diagnostics, medical devices and branded generic pharmaceuticals serving over 150 countries.
Visit www.myfreestyle.ca for more information.